Updated:
HealthXCapital
HealthXCapital (HXC) is an early stage investment platform providing smart, connected capital to healthcare startups focused on emerging markets in South East...
HealthXCapital
HealthXCapital (HXC) is an early stage investment platform providing smart, connected capital to healthcare startups focused on emerging markets in South East Asia and India. HXC is anchored by Jungle Ventures, a leading VC located in Singapore and Apollo Hospitals, the largest healthcare provider in India. It is a venture platform converging clinical providers, commercial partners and startups to address access, affordability, applicability and commercialization in Asia.
General information
Firm type
Private Equity
Year founded
2017
Location
Region
Asia
Country
Singapore
City
Singapore
Corporate office
Singapore
Principals
Seemant Jauhari
Managing Partner
Jimit Patel
Associate
Sanjay Gupta
Venture Partner
Dr. Arda M. Minocherhomjee
Special Advisor
Dr. Daniel Kraft
Special Advisor
Dr. Prem Pillay
Special Advisor
Sector focus
Frequently asked questions
Which portfolio companies has HealthXCapital publicly disclosed?
Publicly disclosed positions include Redcliffe Life Diagnostics, an Indian direct-to-consumer health-testing platform that closed a $61 million Series B led by LeapFrog Investments with HealthXCapital's participation (per Economic Times, 2022). The firm also backed Zyla Health, an AI-driven chronic-care management platform, in a $4 million round alongside Seeders and Supermorpheus (per YourStory, 2023).
Where does HealthXCapital deploy capital geographically?
The firm's primary deployment corridor is India and Southeast Asia, with Singapore as its headquarters. India represents the densest concentration of disclosed deals, reflecting the country's large patient pool, evolving regulatory framework, and deep pipeline of health-tech founders. Southeast Asian markets, including Indonesia, form a secondary but strategically connected footprint.
How does HealthXCapital differ from generalist venture funds that also invest in healthcare?
Unlike generalist Asian VC platforms that opportunistically back one or two health-tech names per fund cycle, HealthXCapital operates with a sector-specific mandate. The firm was built to navigate healthcare's clinical-validation, reimbursement, and regulatory complexity across multiple Asian jurisdictions—a diligence burden that deters funds without dedicated health-sector teams.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: